Discover our latest insights. 

The U.S. Food and Drug Administration (FDA) has approved Blujepa™ (gepotidacin), a novel antibiotic for the treatment of urinary tract infections (UTIs) in adult women. This approval represents a significant advancement in …

Parkinson’s disease (PD) affects more than 10 million people worldwide, with about 90,000 new cases diagnosed annually in the U.S. alone, according to the Parkinson’s Foundation. As the population ages, those numbers …

As of March 21, 2025, the United States is facing a significant measles outbreak, with over 378 confirmed cases, in 18 states. Most of these cases (351) are part of an outbreak …

As we age, our immune system naturally weakens, making adults over 50 more susceptible to serious infections and complications. Yet, many adults may skip, delay or be unaware of crucial vaccinations, putting …

Nearly one million Americans are living with Multiple Sclerosis (MS), according to the National Multiple Sclerosis Society. Although the exact cause of MS remains unclear, it is believed to be an autoimmune …

The H5N1 bird flu isn’t just a poultry issue – it’s a growing global health concern. While human infections remain rare, the virus is closely monitored due to its potential to evolve. …